featured
Lapatinib With Capecitabine Plus Oxaliplatin in HER2+ Advanced Gastroesophageal Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC- A Randomized Phase III Trial
J. Clin. Oncol 2015 Nov 30;[EPub Ahead of Print], JR Hecht, YJ Bang, SK Qin, HC Chung, JM Xu, JO Park, K Jeziorski, Y Shparyk, PM Hoff, A Sobrero, P Salman, J Li, SA Protsenko, ZA Wainberg, M Buyse, K Afenjar, V Houé, A Garcia, T Kaneko, Y Huang, S Khan-Wasti, S Santillana, MF Press, D SlamonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.